serw-MX  [xml]  
 


    
 DeCS Categories

C04 Neoplasms .
C04.557 Neoplasms by Histologic Type .
C04.557.465 Neoplasms, Germ Cell and Embryonal .
C04.557.465.625 Neuroectodermal Tumors .
C04.557.580 Neoplasms, Nerve Tissue .
C04.557.580.625 Neuroectodermal Tumors .
D02 Organic Chemicals .
D02.092 Amines .
D02.092.311 Catecholamines .
D02.092.311.200 Dihydroxyphenylalanine .
D02.092.311.200.480 Levodopa .
D02.092.311.200.538 Methyldopa .
D02.092.311.200.538.200 Carbidopa .
D02.145 Aza Compounds .
D02.145.074 Azabicyclo Compounds .
D02.145.074.722 Tropanes .
D02.145.074.722.270 Benztropine .
D02.241 Carboxylic Acids .
D02.241.223 Acids, Carbocyclic .
D02.241.223.601 Phenylacetates .
D02.241.223.601.600 Methylphenidate .
D02.241.223.601.600.500 Dexmethylphenidate Hydrochloride .
D02.442 Hydrazines .
D02.442.175 Benserazide .
D02.442.200 Carbidopa .
D03 Heterocyclic Compounds .
D03.132 Alkaloids .
D03.132.889 Tropanes .
D03.132.889.244 Benztropine .
D03.383 Heterocyclic Compounds, 1-Ring .
D03.383.621 Piperidines .
D03.383.621.460 Methylphenidate .
D03.383.621.460.500 Dexmethylphenidate Hydrochloride .
D03.605 Heterocyclic Compounds, Bridged-Ring .
D03.605.084 Bridged Bicyclo Compounds, Heterocyclic .
D03.605.084.500 Azabicyclo Compounds .
D03.605.084.500.722 Tropanes .
D03.605.084.500.722.270 Benztropine .
D03.605.869 Tropanes .
D03.605.869.270 Benztropine .
D08 Enzymes and Coenzymes .
D08.811 Enzymes .
D08.811.520 Lyases .
D08.811.520.224 Carbon-Carbon Lyases .
D08.811.520.224.125 Carboxy-Lyases .
D08.811.520.224.125.100 Aromatic-L-Amino-Acid Decarboxylases .
D08.811.520.224.125.100.500 Dopa Decarboxylase .
D12 Amino Acids, Peptides, and Proteins .
D12.125 Amino Acids .
D12.125.072 Amino Acids, Cyclic .
D12.125.072.050 Amino Acids, Aromatic .
D12.125.072.050.685 Phenylalanine .
D12.125.072.050.685.400 Dihydroxyphenylalanine .
D12.125.072.050.685.400.500 Levodopa .
D12.125.072.050.875 Tyrosine .
D12.125.072.050.875.130 Dihydroxyphenylalanine .
D12.125.072.050.875.130.500 Levodopa .
D27 Chemical Actions and Uses .
D27.505 Pharmacologic Actions .
D27.505.954 Therapeutic Uses .
D27.505.954.427 Central Nervous System Agents .
D27.505.954.427.090 Anti-Dyskinesia Agents .
D27.505.954.427.090.050 Antiparkinson Agents .
E01 Diagnosis .
E01.370 Diagnostic Techniques and Procedures .
E01.370.350 Diagnostic Imaging .
E01.370.350.578 Neuroimaging .
E01.370.350.578.937 Neuroradiography .
E01.370.350.700 Radiography .
E01.370.350.700.560 Neuroradiography .
E01.370.376 Diagnostic Techniques, Neurological .
E01.370.376.537 Neuroimaging .
E01.370.376.537.750 Neuroradiography .
E02 Therapeutics .
E02.815 Radiotherapy .
E02.815.230 Craniospinal Irradiation .
E05 Investigative Techniques .
E05.629 Neuroimaging .
E05.629.937 Neuroradiography .
 
 Terms
 Synonyms & Historicals
Documents
LILACS e MDL
 
Benserazide .
DL-Serine 2-((2,3,4-trihydroxyphenyl)methyl)hydrazide .
Ro 4-4602 .
Seryltrihydroxy Benzylhydrazine .
Benzylhydrazine, Seryltrihydroxy .
Ro 4 4602 .
Ro 44602 .
Serazide .
Seryltrihydroxybenzylhydrazine .
An inhibitor of DOPA DECARBOXYLASE that does not enter the central nervous system. It is often given with LEVODOPA in the treatment of parkinsonism to prevent the conversion of levodopa to dopamine in the periphery, thereby increasing the amount that reaches the central nervous system and reducing the required dose. It has no antiparkinson actions when given alone. .
1.00
71036
 
Carbidopa .
Carbidopa, (R)-Isomer .
Carbidopa, (S)-Isomer .
Lodosin .
Lodosyn .
MK-485 .
MK-486 .
MK 485 .
MK 486 .
MK485 .
MK486 .
Methyldopahydrazine .
An inhibitor of DOPA DECARBOXYLASE, preventing conversion of LEVODOPA to dopamine. It is used in PARKINSON DISEASE to reduce peripheral adverse effects of LEVODOPA. It has no antiparkinson actions by itself. .
0.48
132173
 
Levodopa .
3-Hydroxy-L-tyrosine .
Dopaflex .
Dopar .
L-3,4-Dihydroxyphenylalanine .
Larodopa .
Levopa .
3 Hydroxy L tyrosine .
L 3,4 Dihydroxyphenylalanine .
L Dopa .
L-Dopa .
The naturally occurring form of DIHYDROXYPHENYLALANINE and the immediate precursor of DOPAMINE. Unlike dopamine itself, it can be taken orally and crosses the blood-brain barrier. It is rapidly taken up by dopaminergic neurons and converted to DOPAMINE. It is used for the treatment of PARKINSONIAN DISORDERS and is usually given with agents that inhibit its conversion to dopamine outside of the central nervous system. .
0.39
19915124
 
Dopa Decarboxylase .
Decarboxylase, Dopa .
One of the AROMATIC-L-AMINO-ACID DECARBOXYLASES, this enzyme is responsible for the conversion of DOPA to DOPAMINE. It is of clinical importance in the treatment of Parkinson's disease. .
0.37
01066
 
Benztropine .
Apo-Benztropine .
Bensylate .
Benzatropine .
Benzatropine Mesylate .
Benzatropine Methanesulfonate .
Benzatropine Methanesulfonate, Hydrobromide .
Benzatropine Methanesulfonate, Hydrobromide, (endo)-Isomer .
Benzatropine Methanesulfonate, Hydrochloride, (endo)-Isomer .
Benztropine Mesylate .
Cogentin .
Cogentinol .
N-Methylbenztropine .
PMS-Benztropine .
Apo Benztropine .
Hydrobromide Benzatropine Methanesulfonate .
Mesylate, Benzatropine .
Mesylate, Benztropine .
Methanesulfonate, Benzatropine .
Methanesulfonate, Hydrobromide Benzatropine .
N Methylbenztropine .
PMS Benztropine .
A centrally active muscarinic antagonist that has been used in the symptomatic treatment of PARKINSON DISEASE. Benztropine also inhibits the uptake of dopamine. .
0.34
1663
 
Antiparkinson Agents .
Antiparkinson Drugs .
Antiparkinsonian Agents .
Antiparkinsonians .
Agents, Antiparkinson .
Agents, Antiparkinsonian .
Drugs, Antiparkinson .
Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. .
0.33
849896
 
Neuroradiography .
Neuroradiographies .
Radiography of the central nervous system. .
0.33
31992
 
Dexmethylphenidate Hydrochloride .
Focalin .
Focalin XR .
Hydrochloride, Dexmethylphenidate .
XR, Focalin .
Dexmethylphenidate .
A methylphenidate derivative, DOPAMINE UPTAKE INHIBITOR and CENTRAL NERVOUS SYSTEM STIMULANT that is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER. .
0.33
052
 
Craniospinal Irradiation .
Spinocranial Irradiation .
Irradiation, Craniospinal .
Irradiation, Spinocranial .
A comprehensive radiation treatment of the entire CENTRAL NERVOUS SYSTEM. .
0.32
092
 
Neuroectodermal Tumors .
Neuroectodermal Tumor .
Tumor, Neuroectodermal .
Tumors, Neuroectodermal .
Malignant neoplasms arising in the neuroectoderm, the portion of the ectoderm of the early embryo that gives rise to the central and peripheral nervous systems, including some glial cells. .
0.32
17393